The principal mission of the Institut Bordet Department of Surgery is the surgical treatment of cancerous diseases.
More specifically, our surgeons strive to:
- offer leading-edge surgical techniques in the treatment of cancer;
- integrate surgery into global cancer treatment;
- encourage approaches combining surgery and other treatments such as chemotherapy, radiotherapy, nuclear medicine, interventional radiology, immunotherapy, etc;
- promote research and develop innovative treatments;
- collaborate at national and international levels with other cancer centres;
- teach surgery to medical students and future surgeons;
- train surgeons specifically in oncological surgery.
The Institut Bordet Department of Surgery comprises 6 specific fields:
- Cervicofacial and Thoracic Surgery
- Digestive Surgery
- Breast and Pelvic Surgery
- Bone and Connective Tissue Tumour Surgery
- Cancer Reconstructive Surgery
- Skin Tumour Surgery.
In each discipline, the Department of Surgery develops an integrated and individualised approach using leading-edge techniques and technologies.
- In individualised treatment, the aim is to adapt the therapeutic options to each patient. This means that surgical treatment is adapted to meet the specific characteristics of the cancer and the particular circumstances and requests of patients.
- Surgical techniques evolve. New treatments are regularly being developed. Each field of surgery participates in advances in its discipline, both from the viewpoint of diagnostic methods and the treatments themselves. The Institut Bordet follows these developments very closely. Our surgeons train in the latest techniques and the Department of Surgery regularly acquires the new equipment and instruments needed to develop new treatment options.
- Surgical treatments are always integrated into global patient care as part of a multidisciplinary collaboration. The Department and the Hospital are organised to help optimise these collaborations between the different surgical disciplines and with all the departments involved in patient care and treatment. In each field, treatments are discussed on a weekly basis at multidisciplinary cancer care meetings (CMOs) involving different specialist doctors.
The Institut Bordet Department of Surgery is involved in teaching in the Faculty of Medicine, on different inter-university diploma courses and in the Hautes Écoles nursing colleges.
The Department of Surgery teaches surgery to students from the Faculty of Medicine and, in particular, the specificities of oncological surgery. This teaching is also delivered to students and young doctors coming from abroad.
Study of the contribution of Fluorescence Imaging in the diagnosis and staging of cancer.
- Collaborations : Group R&D for the Clinical Application of Fluorescence Imaging, Institut Jules Bordet
- Funding : Les Amis de l'Institut Bordet
Study of immunogenicity and immune response in hepatocellular carcinoma.
- Collaborations : Institut d’Immunologie médicale (IMI), ULB, Institut De Duve (UCL).
- Funding : FNRS, Les Amis de l'Institut Bordet
Head of Department
Prof Vincent Donckier
Pr Gabriel Liberale, Head of Clinic
Pr Vincent Donckier
Dr Fikri Bouazza
Pr Issam El Nakadi
Dr Florin Pop
Pr Jean Van de Stadt
Cervicofacial and Thoracic Surgery
Dr Antoine Digonnet, Head of Clinic
Dr Esther Willemse
Dr Marie Quiriny
Dr Samuel Lipski (ENT specialist)
Dr Cécile Dekeyser (ENT specialist)
Pr Guy Andry, Honorary Professor of Surgery
Senior Nurses – In-patient unit
Fabienne Van Ginderachter
Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI).
Authors : Lo Dico R, Faron M, Yonemura Y, Glehen O, Pocard M, Sardi A, Hübner M, Baratti D, Liberale G, Kartheuser A, de Hingh I, Sugarbaker P, Ceelen W, Moran B, Robella M, Quenet F, Sideris L, Goere D, Limbert M, Sammartino P, Morris D
Year : 2020
Journal : Eur J Surg Oncol
Myeloid TNF and HO-1 regulate the progression of colorectal liver metastases during hepatic ischemia-reperfusion.
Authors : Germanova D, Keirsse J, Köhler A, Hastir JF, Demetter P, Delbauve S, Elkrim Y, Verset L, Larbanoix L, Preyat N, Laurent S, Nedospasov S, Donckier V, Van Ginderachter JA, Flamand V
Year : 2020
Journal : Int J Cancer
Une approche radicale visant à obtenir une cytoréduction chirurgicale complète améliore la survie des patientes atteintes d’un cancer avancé de l’ovaire. Radical approaches that aim to achieve complete cytoreductive surgery improve survival of patien
Authors : Liberale G, Pop FC, Polastro L, Kerger J, Moreau M, Chintinne M, Larsimont D, Nogaret JM, Veys I
Year : 2020
Journal : J Magn Reson Imaging
Volume : 157(2)
Pages : 80-88
A rare presentation of small diaphragmatic epidermoid cyst with extremely elevated serum CA19-9 level.
Authors : El-Khoury M, Bohlok A, Sleiman YA, Loi P, Coppens E, Demetter P, El Nakadi I
Year : 2020
Journal : Ann R Coll Surg Engl
Volume : 102
Pages : e23-e25
Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis
Authors : El Asmar A, Bendavides M, Moreau M, Hendlisz A, Deleporte A, Khalife M, Donckier V, Liberale G
Year : 2020
Journal : World J Surg Oncol
Volume : -
Pages : -